Moreover, our results suggest that the reduction in dopamine levels associated with gut inflammation and the consequent shift in dopamine receptors stimulated in the Drd2:Drd3 heteromer expressed on mucosal Treg cells represents one of the molecular changes responsible for the Treg unresponsiveness observed in the gut mucosa of IBD patients. This evidence concerns the gene DRD2 and inflammatory bowel disease.